Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Novel selective D3R ligands for the treatment of drug addiction

May 19, 2022

M1 mAChR antagonism attenuates opioid drug seeking behaviors in rat

May 5, 2022

CNRS and collaborators patent acetylcholinesterase reactivators

April 1, 2022

Red Bull GmbH presents dopamine reuptake inhibitors

Jan. 20, 2022

Metabotropic glutamate mGlu2 receptor found to be associated with alcoholism

Nov. 30, 2021

Researchers develop a rat model of oxycodone/cocaine withdrawal syndrome

Nov. 23, 2021

One-year challenge data from preclinical study of ATI-1701 in lethal model of tularemia

Nov. 22, 2021

New and known compounds targeting PTPRD may treat AD, addiction and restless legs syndrome

Nov. 4, 2021

New treatment targets identified in opiate abstinence

Nov. 3, 2021

RM-1490, a novel MOR agonist as maintenance therapeutic in opioid use disorder

Nov. 2, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 16, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...